Latest News for: cdh17

Edit

FDA Grants Fast Track Designation to SOTIO’s SOT109, a CDH17-targeting ADC for Colorectal Cancer

Nasdaq Globe Newswire 14 Jul 2026
SOTIO's ADC, SOT109, given Fast Track Designation for advanced unresectable or metastatic colorectal cancer who have exhausted standard treatment options ... .
Edit

InnoCare Announces First Patient Dosed in Clinical Trial of Novel CDH17 targeted ADC ICP-B208

Caledonian Record 06 Jul 2026
09969; SSE.
Edit

InnoCare Announces First Patient Dosed in Clinical Trial of Novel CDH17 targeted ADC ICP-B208 in China

Killeen Daily Herald 06 Jul 2026
BEIJING, July 05, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX. 09969; SSE. 688428), a leading biopharmaceutical ....
Edit

InnoCare Announces First Patient Dosed in Clinical Trial of�Novel CDH17 targeted ADC ICP-B208 in China

Nasdaq Globe Newswire 06 Jul 2026
ICP-B208 is InnoCare's second ADC from its in-house platform to enter clinical development. There are no approved CDH17 targeted ADCs globally ... .
Edit

Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program

PR Newswire 21 Apr 2026
"We remain focused on supporting Chimeric as the CDH17 program advances through clinical development, with an emphasis on reliable supply and dependable product release." ... CHM CDH17 is a ...
  • 1

Article Search

tools
×
×
×
×